# Bioavailability and Vascular Effects of Apple Polyphenols

> **NCT01097226** · NA · COMPLETED · sponsor: **Quadram Institute Bioscience** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Apple extract delivering 70 mg epicatechin
- **OTHER:** Apple extract delivering 140 mg epicatechin
- **OTHER:** Apple granules delivering 70 mg epicatechin
- **OTHER:** Water delivering no epicatechin

## Key facts

- **NCT ID:** NCT01097226
- **Lead sponsor:** Quadram Institute Bioscience
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097226, "Bioavailability and Vascular Effects of Apple Polyphenols". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01097226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
